TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 122 filers reported holding TCR2 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $37,000 | -51.9% | 13,342 | -19.0% | 0.00% | – |
| Q4 2021 | $77,000 | -75.4% | 16,469 | -55.2% | 0.00% | – |
| Q3 2021 | $313,000 | -54.6% | 36,768 | -12.6% | 0.00% | -100.0% |
| Q2 2021 | $690,000 | -28.4% | 42,061 | -3.7% | 0.00% | 0.0% |
| Q1 2021 | $964,000 | -18.9% | 43,659 | +13.6% | 0.00% | -50.0% |
| Q4 2020 | $1,189,000 | +52.2% | 38,448 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $781,000 | +107.2% | 38,448 | +56.5% | 0.00% | 0.0% |
| Q2 2020 | $377,000 | +163.6% | 24,561 | +33.0% | 0.00% | – |
| Q1 2020 | $143,000 | -45.2% | 18,463 | +1.1% | 0.00% | – |
| Q4 2019 | $261,000 | -4.7% | 18,254 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $274,000 | +602.6% | 18,254 | +568.2% | 0.00% | – |
| Q2 2019 | $39,000 | – | 2,732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 3,370,982 | $68,498,000 | 16.50% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $82,314,000 | 15.35% |
| Consonance Capital Management LP | 1,509,819 | $30,680,000 | 3.74% |
| Soleus Capital Management, L.P. | 282,041 | $5,731,000 | 3.04% |
| Redmile Group, LLC | 2,793,288 | $56,760,000 | 1.04% |
| PFM Health Sciences, LP | 775,794 | $15,764,000 | 0.73% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,200,000 | $24,384,000 | 0.59% |
| Cormorant Asset Management, LP | 600,000 | $12,192,000 | 0.47% |
| Sofinnova Investments, Inc. | 173,028 | $3,516,000 | 0.26% |
| Artal Group S.A. | 500,000 | $10,160,000 | 0.25% |